Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Genmab
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
Atavistik Bio, Inc
M.D. Anderson Cancer Center
University of Miami
Natera, Inc.
National Institutes of Health Clinical Center (CC)
Seagen Inc.
University Health Network, Toronto
Washington University School of Medicine
Washington University School of Medicine
Sensei Biotherapeutics, Inc.
Jonsson Comprehensive Cancer Center
University of Alabama at Birmingham